Cargando…

Deficiency of the frontotemporal dementia gene GRN results in gangliosidosis

Haploinsufficiency of GRN causes frontotemporal dementia (FTD). The GRN locus produces progranulin (PGRN), which is cleaved to lysosomal granulin polypeptides. The function of lysosomal granulins and why their absence causes neurodegeneration are unclear. Here we discover that PGRN-deficient human c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boland, Sebastian, Swarup, Sharan, Ambaw, Yohannes A., Malia, Pedro C., Richards, Ruth C., Fischer, Alexander W., Singh, Shubham, Aggarwal, Geetika, Spina, Salvatore, Nana, Alissa L., Grinberg, Lea T., Seeley, William W., Surma, Michal A., Klose, Christian, Paulo, Joao A., Nguyen, Andrew D., Harper, J. Wade, Walther, Tobias C., Farese, Robert V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546883/ https://www.ncbi.nlm.nih.gov/pubmed/36207292 http://dx.doi.org/10.1038/s41467-022-33500-9

Ejemplares similares

Astroglial toxicity promotes synaptic degeneration in the thalamocortical circuit in frontotemporal dementia with GRN mutations
por: Marsan, Elise, et al.
Publicado: (2023)

Modelling the cascade of biomarker changes in GRN-related frontotemporal dementia
por: Panman, Jessica L, et al.
Publicado: (2021)

Biochemical, biomarker, and behavioral characterization of the Grn(R493X) mouse model of frontotemporal dementia
por: Smith, Denise M., et al.
Publicado: (2023)

Elevated levels of extracellular vesicles in progranulin‐deficient mice and FTD‐GRN Patients
por: Arrant, Andrew E., et al.
Publicado: (2020)

Distinct cell type-specific protein signatures in GRN and MAPT genetic subtypes of frontotemporal dementia
por: Miedema, Suzanne S. M., et al.
Publicado: (2022)

Variation at GRN 3′-UTR rs5848 Is Not Associated with a Risk of Frontotemporal Lobar Degeneration in Dutch Population
por: Simón-Sánchez, Javier, et al.
Publicado: (2009)

Patients with sporadic FTLD exhibit similar increases in lysosomal proteins and storage material as patients with FTD due to GRN mutations
por: Davis, Skylar E., et al.
Publicado: (2023)

Case report: TMEM106B haplotype alters penetrance of GRN mutation in frontotemporal dementia family
por: Perneel, Jolien, et al.
Publicado: (2023)

Disrupted myelin lipid metabolism differentiates frontotemporal dementia caused by GRN and C9orf72 gene mutations
por: Marian, Oana C., et al.
Publicado: (2023)

Mice lacking triglyceride synthesis enzymes in adipose tissue are resistant to diet-induced obesity
por: Chitraju, Chandramohan, et al.
Publicado: (2023)

Investigating the role of filamin C in Belgian patients with frontotemporal dementia linked to GRN deficiency in FTLD-TDP brains
por: Janssens, Jonathan, et al.
Publicado: (2015)

Intracellular Proteolysis of Progranulin Generates Stable, Lysosomal Granulins that Are Haploinsufficient in Patients with Frontotemporal Dementia Caused by GRN Mutations
por: Holler, Christopher J., et al.
Publicado: (2017)

Neuropathological and behavioral characterization of aged Grn R493X progranulin-deficient frontotemporal dementia knockin mice
por: Frew, Jonathan, et al.
Publicado: (2021)

Impaired β-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations
por: Arrant, Andrew E., et al.
Publicado: (2019)

Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia
por: Rademakers, Rosa, et al.
Publicado: (2008)

Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: a novel therapeutic lead to treat frontotemporal dementia
por: Holler, Christopher J., et al.
Publicado: (2016)

Plasma Small Extracellular Vesicles with Complement Alterations in GRN/C9orf72 and Sporadic Frontotemporal Lobar Degeneration
por: Bellini, Sonia, et al.
Publicado: (2022)

Targeting nonsense-mediated RNA decay does not increase progranulin levels in the Grn (R493X) mouse model of frontotemporal dementia
por: Smith, Denise M., et al.
Publicado: (2023)

Plasma Small Extracellular Vesicle Cathepsin D Dysregulation in GRN/C9orf72 and Sporadic Frontotemporal Lobar Degeneration
por: Bellini, Sonia, et al.
Publicado: (2022)

Lack of a protective effect of the Tmem106b “protective SNP” in the Grn knockout mouse model for frontotemporal lobar degeneration
por: Cabron, Anne-Sophie, et al.
Publicado: (2023)

Neuropsychiatric symptoms and imbalance of atrophy in behavioral variant frontotemporal dementia
por: Sokołowski, Andrzej, et al.
Publicado: (2023)

Preferential tau aggregation in von Economo neurons and fork cells in frontotemporal lobar degeneration with specific MAPT variants
por: Lin, Li-Chun, et al.
Publicado: (2019)

Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory
por: Ljubenkov, Peter A., et al.
Publicado: (2018)

Genetics and Therapies for GM2 Gangliosidosis
por: Cachón-González, María Begoña, et al.
Publicado: (2018)

GM1 Gangliosidosis: Mechanisms and Management
por: Rha, Allisandra K, et al.
Publicado: (2021)

Anterior insula degeneration in frontotemporal dementia
por: Seeley, William W.
Publicado: (2010)

Profiling of Ubiquitination Pathway Genes in Peripheral Cells from Patients with Frontotemporal Dementia due to C9ORF72 and GRN Mutations
por: Serpente, Maria, et al.
Publicado: (2015)

Mutation Frequency of the Major Frontotemporal Dementia Genes, MAPT, GRN and C9ORF72 in a Turkish Cohort of Dementia Patients
por: Guven, Gamze, et al.
Publicado: (2016)

Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations
por: Huang, Meixiang, et al.
Publicado: (2020)

Rates of Brain Atrophy Across Disease Stages in Familial Frontotemporal Dementia Associated With MAPT, GRN, and C9orf72 Pathogenic Variants
por: Staffaroni, Adam M., et al.
Publicado: (2020)

AAV-GRN partially corrects motor deficits and ALS/FTLD-related pathology in Tmem106b(−/−)Grn(−/−) mice
por: Feng, Tuancheng, et al.
Publicado: (2023)

Animal models of GM2 gangliosidosis: utility and limitations
por: Lawson, Cheryl A, et al.
Publicado: (2016)

GM1 Gangliosidosis—A Mini-Review
por: Nicoli, Elena-Raluca, et al.
Publicado: (2021)

An 8-week, open-label, dose-finding study of nimodipine for the treatment of progranulin insufficiency from GRN gene mutations
por: Sha, Sharon J., et al.
Publicado: (2017)

A novel frameshift GRN mutation results in frontotemporal lobar degeneration with a distinct clinical phenotype in two siblings: case report and literature review
por: Hosaka, Takashi, et al.
Publicado: (2017)

The PINK1 p.Asn521Thr Variant Is Associated with Earlier Disease Onset in GRN/C9orf72 Frontotemporal Lobar Degeneration
por: Rossi, Giacomina, et al.
Publicado: (2022)

Novel GRN Mutations in Patients with Corticobasal Syndrome
por: Taghdiri, Foad, et al.
Publicado: (2016)

GM1gangliosidosis: Clinical and radiological clue to diagnosis
por: Suthar, Renu, et al.
Publicado: (2012)

Characterization of glycan substrates accumulating in GM1 Gangliosidosis
por: Lawrence, Roger, et al.
Publicado: (2019)

GM1‐Gangliosidosis Type III Associated Parkinsonism
por: Kaiyrzhanov, Rauan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g9mjdq8abvlv0noh5kgldvhlui